好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Phase I Clinical Trial Demonstrates Safety and Efficacy of Intrathecal Autologous Mesenchymal Stem Cell-Derived Neural Progenitors (MSC-NPs) for the Treatment of Progressive Multiple Sclerosis
Multiple Sclerosis
P5 - (-)
378
Authors/Disclosures
Violaine K. Harris, PhD (Tisch Multiple Sclerosis Research Center of NY)
PRESENTER
No disclosure on file
James Stark, MD, FAAN (IMSMP) Dr. Stark has nothing to disclose.
Gloria J. Joo (Tisch MS Research Center of NY) No disclosure on file
Tamara Vyshkina, PhD (Tisch Multiple Sclerosis Research Ctr of NY) No disclosure on file
Saud Sadiq, BS, FAAN (Tisch Multiple Sclerosis Research Center of New York) Ms. Brewi has nothing to disclose.